
ãã³ãããã¯æã«æ¥å¢ããè¥å¹Žå±€ã®æ»äº¡çãããããªãïŒ
å èšäºã¯ãã¡ããã/Click here to read the original article.
JAMA Network Openã«æ¬æ¥æ²èŒãããè«æã«ãããšã25æ³ãã44æ³ã®æäººã®æ»äº¡çã¯ããæ°å¹Žã§æ¥äžæããŠããããã®åå ã¯è¬ç©äœ¿çšãšããã®ä»ã®å€å ããã³èªç¶åå ãã§ããããã®è«æã§ã¯ãã¯ã¯ãã³ãæžç· ãŸããšãã£ãCOVID-19ãã³ãããã¯å¯Ÿçã¯èæ ®ãããŠããªãããšæ¹è©å®¶ã¯è¿°ã¹ãŠããã
JAMA Network Openã«æ¬æ¥çºè¡šãããè«æã«ãããšã25ïœ44æ³ã®æäººã®æ»äº¡çã¯ãCOVID-19ãã³ãããã¯ãšæãåããããŠ2020幎ãã2023幎ã«ãããŠæ¥äžæããã
ãã®è«æã¯ã1999幎ãã2023幎ãŸã§ã®ç±³åœã«ãããæäººæ©æã®éå°æ»äº¡çã調æ»ããæäººæ©æã®æ»äº¡çã¯2011幎ãã2019幎ã2020幎ãã2023幎ã®2段éã§ãå€§å¹ ã«äžæããããšçµè«ããŠããã
ãã®ã°ã«ãŒãã®éå°æ»äº¡çã¯ãã³ãããã¯æã«ããŒã¯ã«éãããã®åŸæžå°ãããããã³ãããã¯åã®ã¬ãã«ã«ã¯éããŠããªãã
2023幎ãŸã§ã®è¶ éæ»äº¡çã®æå€§ã®èŠå ã¯ãè¬ç©äžæ¯ãã§ãã£ããããããããã®ä»ã®å€å ããã³èªç¶æ»å ã¯ãäºåã®ãã¬ã³ããäºæž¬ãããã®ãäžåã£ãããšããã
èè ãã¯ããã®å¹Žéœ¢å±€ã®æ»äº¡å±æ©ã¯ãæªåãããŠãããæ¿çççµè«ãšããŠããªããªã€ã䜿çšãã¢ã«ã³ãŒã«æåã亀éå®å šãé£äºãªã¹ã¯ãªã©ãæ»äº¡çè¶ éã®æ¿åããåå ã«å¯ŸåŠãã¹ãã§ãããšçµè«ã¥ããã
ãŸãã2020幎以åãšä»¥åŸã®æ»äº¡çå¢å ã®2ã€ã®ãæç¢ºãªæ®µéãã¯ããCOVID-19ãã³ãããã¯ã®ç¶ç¶çãªåœ±é¿ã«æ³šæãæãå¿ èŠæ§ã瀺åããŠãããããããªãããšææããã
ããšãŒã«ã»ã³ãªãŒå士ã¯ãéå°æ»äº¡çã®ççºçãªäžæãšã¯ã¯ãã³å±éãšã®æéçé¢é£ã«æ³šæãåèµ·ããè«æãäœæ¬ãæžããŠãããããã®è«æã¯ã¯ã¯ãã³ã®åœ±é¿ã«ã€ããŠè§ŠããŠããªããšéé£ããã
ããã®ãããªè«æãèªããšãã¯ã¯ãã³ã®åœ±é¿ã«ã€ããŠèšåãããŠããªãïŒèšåã§ããªãïŒãããåç§åŠçã§ãããæ¬è³ªçã«è§£éäžå¯èœã§ããã
ãçµè«ã®äžã§ãmRNAãã£ã³ããŒã³ã®æœåšçãªåœ±é¿ã«ã€ããŠã¯è§ŠããããŠããŸããããã®ä»£ããã«ããã³ãããã¯ã®ç¶ç¶çãªåœ±é¿ã«æ³šæãæãå¿ èŠããããããããªãããšè¿°ã¹ãŠããã
ãã³ãããã¯å¯Ÿçãšå šæ»å æ»äº¡çã®é¢é£æ§ãåºãåæããŠããå šæ»å æ»äº¡çç ç©¶è ããã¹ã»ã©ã³ã³ãŒãå士ã«ããã°ããã®ãããªç ç©¶ã¯æ ¹æ¬çãªæ»å ãåãããšããæ ã£ãŠãããšããã
èè ãã¡ã¯ãè¬ç©ãã¢ã«ã³ãŒã«ã®äœ¿çšãšãã£ãè¿æ¥çãªæ»å ã«ã€ããŠã¯å ±åããŠããããäŸãã°ãããã¯ããŠã³ã®çµæãšããŠèµ·ãã£ãéçšã®åªå€±ãæçŸ©ã®åªå€±ãšãã£ãæ ¹æ¬çãªæ»å ã«ã€ããŠã¯èšåããŠããªãããšã©ã³ã³ãŒãæ°ã¯èšãã
ã©ã³ã³ãŒãæ°ã¯ããã®ãããªèšäºã¯ ãæå³çã«éèŠãªããšãè¿°ã¹ãŠããªã ããšè¿°ã¹ãã
ããã®ãããªèšäºããªãããªã³ã»ãªãŒãã£ã³ã°ã»ãžã£ãŒãã«ã«æ²èŒãããã®ã¯ãæãããäžèª å®ãªããšã ããç§ãã¡ãç€Œåæ£ããå€äº€çã§ãããããšæããªãããããã§äœãèµ·ãã£ãŠããã®ãã«ã€ããŠæ¬é³ã§èªããªããšããã®ã¯ãå®å šã«äžèª å®ã§ããã
ã³ãªãŒæ°ã¯ãã¯ã¯ãã³æå®³äºè±¡å ±åã·ã¹ãã ïŒVAERSïŒã«å ±åãããæ»äº¡äŸãããåŒ·å¶æ¥çš®ã倧æµè¡ãã2021幎第3ååæã«çªç¶çºçããã25-44æ³ã®è¥è ã®å£äœå®æä¿éºè«æ±ã®äžå¯è§£ã§åäŸã®ãªãäžæããªã©ãä»ã®ããŒã¿ãããã¯ã¯ãã³æ¥çš®ãšéå°æ»äº¡çã®æéçé¢ä¿ã«ã€ããŠéèŠãªçåãæµ®ãã³äžãã£ãããè«æã§ã¯åãäžããããªãã£ããšä»ãå ããã
èè ãã¯æ»å ã«é¢ããéèŠãªè³ªåãæ ã£ã
èè ãã¯ãç±³åœçŸç äºé²ç®¡çã»ã³ã¿ãŒïŒCenters for Disease Control and PreventionïŒã«ããæ»å ãå«ãããŒã¿ãšãç±³åœåœå¢èª¿æ»å±ïŒU.S. Census BureauïŒã«ãã1999幎ãã2023幎ãŸã§ã®24æ³ãã44æ³ã®æäººã®äžéå¹Žäººå£æšèšãçšããŠãæ¯æã®æ»äº¡çãç®åºããã圌ãã¯1999幎ãã2010幎ãŸã§ã®æ»äº¡çã®ã¢ãã«ãäœæãã2011幎ãã2023幎ãŸã§ã®äºæ³æ»äº¡çã®åŸåãäºæž¬ããã
COVID-19ãé€ãåæ»å ã«ã€ããŠãå幎ã®èг坿»äº¡çãšæåŸ æ»äº¡çã®å·®ãèšç®ããè¶ éæ»äº¡çãç®åºããã
ãã®çµæãåæãããã¹ãŠã®æ»å ã«ã€ããŠã2011幎以éã«äºæ³ãããæ»äº¡çãããææã«å€ãã®è¶ éæ»äº¡ãããããšãããã£ãã圌ãã®èšç®ã«ãããšãæäººã®åæéå°æ»äº¡çã¯2019幎ã«äºæ³ãã34.6ïŒ é«ããªãããCOVID-19ãã³ãããã¯ã®éã«ããã«å éãããã
ãã³ãããã¯ã®æçæã§ãã2021幎ã«ã¯ãå šæ»å ã«ããéå°æ»äº¡çã¯2019幎ã®çŽ3åïŒ10äžäººåœããã®æ»äº¡æ°41.7人ã«å¯Ÿã116.2人ïŒã§ãã£ããšå ±åããŠããã
2023幎ãŸã§ã«ã¯ãéå°æ»äº¡çã¯äœäžãããã2019幎ãš2021幎ã®ã¬ãã«ã®äžéãŸã§ããäœäžããªãã£ããšããã2023幎ãæäººæ©ææ»äº¡çã¯ã2011幎以åã®ãã¬ã³ããç¶ããŠããå Žåã«äºæ³ãããæ»äº¡çããã70ïŒ é«ããŸãŸã§ãã£ãã
2023幎ãŸã§ã«ããã®é«ãæ»äº¡çã®4åã®3ãå ãã5ã€ã®æ»å ã¯ãè¬ç©äžæ¯ïŒ31.8ïŒ ïŒããæ®åèªç¶æ»ãïŒ16ïŒ ïŒã亀éé¢é£æ»ïŒ14.1ïŒ ïŒãã¢ã«ã³ãŒã«é¢é£æ»ïŒ8.5ïŒ ïŒã殺人ïŒ8.2ïŒ ïŒã§ãã£ãã
ãŸããè¥æºãç³å°¿ç ãè³åäžãå¿äžå šãå«ãå¿ä»£è¬æ§çŸæ£ãæ»äº¡ã®9.2ïŒ ãå ããŠããã
ã©ã³ã³ãŒãæ°ã«ããã°ããã®è«æã®æ¹æ³è«ã«ã¯æ·±ãæ¬ é¥ãããããçŸç¶ã®ãŸãŸã§ã¯ç§ã®æ»èªãééããªãã£ãã ãã ããšã®ããšã§ããã
ã1999幎ãã2010幎ãåºæºãšããŠããã®åŸåã2023幎ãŸã§å€æ¿ããåå å¥ã®éå°æ»äº¡ãæ±ãããšãã圌ãã®æ¹æ³ã¯ãçãããããæ£åœåã§ããªããããŸããããŒã¹ã©ã€ã³ïŒ1999-2010幎ïŒãšå€æ¿æéïŒ2011-2023幎ïŒãéããŠã25-44æ³ã®ã³ããŒãå ã®å¹Žéœ¢æ§æãã©ã®çšåºŠå€åããŠããã®ããæ»äº¡çåŸåã®æ¥µããŠéèŠãªæ±ºå®èŠå ã§ããããšãæ€èšŒããŠå ±åããŠããªãã
Rancourtæ°ã«ãããšãèè ãã¯COVID-19以å€ã®ãã¹ãŠã®æ»å ã«ã€ããŠç°ãªãæ¹æ³ãçšããŠããããšãã«ããŒããŠãããä»ã®æ»å ã§ã¯æšå®ãããããŒã¹ã©ã€ã³ããéå°æ»äº¡ã倿¿ããããCOVID-19ã§ã¯åã«COVID-19ã«å²ãåœãŠãããæ»äº¡å ±åæ°ãçšããã
圌ãã¯æ¬è³ªçã«ããªã³ãŽãšãªã¬ã³ãžãæ¯èŒããŠããããšåœŒã¯èšã£ãã
ã³ãªãŒã¯ããã®è«æã®COVID-19ã«ããæ»äº¡è æ°ããè³éããã ãšèšã£ããã¯ã¯ãã³ãå©çšå¯èœã§ããã«ããããããã2021幎ã«COVID-19ã«ããæ»äº¡è ã倧éã«å ±åãããŠããããã ãããã®ã°ã©ãããã¯ã¯ã¯ãã³ãå¹ããããã«ã¯èŠããªãã
ãŸããã2020幎ã«å§ãŸãã仿¥ãŸã§å¢ãç¶ããŠãã ããã®ä»ã®èªç¶æ» ãã®ã«ããŽãªã®æ¥ã§äžå®ã®äžæãè³éãã§ããããèªç¶æ» ãã®ãããªåå ã§ããªãããã»ã©å€ãã®è¥è ãçªç¶æ»äº¡ããã®ã ãããïŒ
圌ã¯ãæ¶ååšç³»ãå åæ³ç³»ãããã®ä»å€éš ããå«ãä»ã®ã«ããŽãªãŒã§ãã2021幎ãã2022幎ã«ãããŠããŒã¯ã瀺ãããã®åŸéåããŠããããšãææããã
ã³ãŒãªãŒã¯èšãïŒ
ãªãèè ãã¡ã¯ããããã® ããã®ä»ã®ã«ããŽãªãŒ ããããã«æ·±ãæãäžãããããã®æ»å ãäœãªã®ãããªãçªç¶è¥ã人ãã¡ã«å€ãçºçããã®ããçè§£ããããšããå¿ èŠæ§ãè«ããªãã®ã§ããããïŒ
ãã®è¬ã¯ããã®ããºã«ã®æ¬ ããŠããããŒã¹ã眮ãã°è§£ãããšç§ã¯ä¿¡ããŠããããæ¬ ããŠããããŒã¹ ããšã¯ãmRNAãã£ã³ããŒã³ããããã®è¬ã®æ»ã«å€§ããè²¢ç®ããå¯èœæ§ã§ãããå°ãªããšããå¯èœæ§ãšããŠè°è«ãããã¹ãã ããèšåãããã¹ããªã®ã ã
ãã©ã³ã³ãŒãæ°ã¯ãŸããèè ãéå°æ»äº¡ããããããæ ¹æ¬çãªåå ã«ã€ããŠã®çåã調æ»ããªãã£ãã®ã¯ã²ã©ããšè¿°ã¹ãã
ããèªåããã®è«æãèªãã§ãããã"æ ¹æ¬çãªæ»å ã«è§Šããã«ãã®ãããªè«æãæžãããšã«äœã®æå³ãããã®ãïŒå€ãã®å倧ãªç§åŠè ãèšã£ãŠãããæå³çã«ãæ æã«ãçŸå®ã«èµ·ãã£ãŠããããšã«ç®ãã€ã¶ããäºæ¬¡çãªåœ±é¿ãå ±åããããšã¯ã§ããªãã®ã§ããã
ã©ã³ã³ãŒãæ°ã«ããã°ãå»çãã¹ãã¯ã¯ãã³ã®æ¯æ§ãªã©ã«ããæ»äº¡ãããã«èµ·ãããããé«éœ¢è éå£ã§ã¯ãªããè¥å¹Žè éå£ã察象ãšããããšã§ãèè ãã¯ãã³ãããã¯ã«é¢é£ããéèŠãªåé¡ãžã®å¯ŸåŠããã容æã«åé¿ããããšãã§ãããšããã